PsyBio Therapeutics Initiates Pilot Scale Development of Proprietary Biosynthetic Psilocybin with Global Contract… Mar 2, 2021
Accessible Neuroimaging Could Change Future of Psychedelic Therapy; Cybin’s Newest Collaboration Feb 28, 2021
PsyBio Therapeutics Comes To Market With Compelling Psychedelic Compound Synthesis Technology Feb 25, 2021
Insufficient Qualified Healthcare Professionals Prompts Demand for Psychedelic Training Programs Feb 24, 2021
MYND Life Sciences Signs Collaborative Research Agreement with UBC to Study Major Depression Feb 6, 2021
